StockData
Obsidian Therapeutics, Inc. logo

Obsidian Therapeutics, Inc. (OBX) stock

OBXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$12.00−0.15 (-1.23%)

Close on Nov 20, 2026Market cap $741.28MP/E –Yield –

Obsidian Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Obsidian Therapeutics's total assets was $340.74M at Sep 30, 2026. For fiscal 2025 it was $88.58M.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$88.58M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$340.74M–
Q2 FY2026Jun 30, 2026$0–
Q4 FY2025Dec 31, 2025$88.58M–

More Obsidian Therapeutics figures

See a number that looks wrong?